Search Within

Leonard B Saltz

Formats
  1. Journal Article (483)
  2. Meeting Abstract (254)
  3. Book Section (24)
  4. Guidelines (10)
  5. Editorial (8)
  6. Correspondence (5)
  7. Review (3)
  8. Book Whole (2)
  9. Conference Paper (2)
  10. Research Letter (1)
Groups
  1. Department of Medicine (792)
  2. Gastrointestinal Oncology Service (792)
  3. Solid Tumor Oncology Division (792)
  4. Center for Pancreatic Cancer Research (308)
  5. Surgery (232)
  6. Survivorship Research (231)

More Groups

People
  1. Martin Weiser (133)
  2. Andrea Cercek Hanjis (126)
  3. Philip Paty (122)
  4. Jinru Shia (100)
  5. Nancy Kemeny (98)
  6. Jose Guillem (89)

More People

Years
  1. 2025 (12)
  2. 2024 (21)
  3. 2023 (24)
  4. 2022 (22)
  5. 2021 (18)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (271)
  2. Journal of the National Comprehensive Cancer Network (42)
  3. Annals of Oncology (36)
  4. Cancer (31)
  5. Clinical Cancer Research (27)
  6. Annals of Surgical Oncology (23)

More Publications

Publishers
  1. American Society of Clinical Oncology (287)
  2. Oxford University Press (82)
  3. Elsevier Inc. (73)
  4. Springer (45)
  5. Harborside Press (42)
  6. American Association for Cancer Research (41)

More Publishers

Results (792)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preoperative treatment of locally advanced rectal cancer
    Journal Article

    Schrag, D.; Qian, S.; Weiser, M. R.; Gollub, M. J.; Saltz, L. B.; Musher, B. L.; Goldberg, J.; Al Baghdadi, T.; Goodman, K. A.; McWilliams, R. R.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Effect of somatic-germline genomic integration on the contribution of pathogenic germline genetic variants (gPV) to colorectal cancer (CRC) carcinogenesis
    Meeting Abstract

    Harrold, E.; Walch, H. S.; Chatila, W. K.; Kemel, Y.; Borio, M.; Maio, A.; Khurram, A.; Salo-Mullen, E. E.; Latham, A.; Murciano-Goroff, Y. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
    Meeting Abstract

    Cohen, R.; Raeisi, M.; Shi, Q.; Chibaudel, B.; Yoshino, T.; Zalcberg, J. R.; Adams, R.; Cremolini, C.; Van Cutsem, E.; Heinemann, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The significance of mucin on rectal MRI in patients with locally advanced rectal cancer being considered for watch-and-wait after neoadjuvant therapy
    Meeting Abstract

    Judge, S.; Malekzadeh, P.; Corines, M. J.; Gollub, M. J.; Horvat, N.; Saltz, L. B.; Cercek, A.; Romesser, P. B.; Crane, C. H.; Wei, I. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long course chemoradiation versus short course radiation therapy
    Meeting Abstract

    Romesser, P. B.; Park, B. K.; Pappou, E.; Nemirovsky, D.; Alvarez, J.; Omer, D. M. R.; Sarkar, R.; Verheij, F. S.; Reyngold, M.; Wu, A. J. C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Sustained organ preservation in patients with rectal cancer treated with total neoadjuvant therapy: Long-term results of the OPRA trial
    Meeting Abstract

    Verheij, F. S.; Omer, D. M. R.; Williams, H.; Buckley, J. T.; Lin, S. T.; Qin, L. X.; Thompson, H. M.; Yuval, J. B.; Gollub, M. J.; Wu, A. J. C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048)
    Meeting Abstract

    Schrag, D.; Shi, Q.; Weiser, M. R.; Gollub, M. J.; Saltz, L. B.; Musher, B. L.; Goldberg, J.; Al Baghdadi, T.; Goodman, K. A.; McWilliams, R. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Evaluation of intratumoral response heterogeneity in metastatic colorectal cancer and its impact on patient overall survival: Findings from 10,551 patients in the ARCAD database
    Journal Article

    Ou, F. S.; Ahn, D. H.; Dixon, J. G.; Grothey, A.; Lou, Y.; Kasi, P. M.; Hubbard, J. M.; Van Cutsem, E.; Saltz, L. B.; Schmoll, H. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048)
    Journal Article

    Basch, E.; Dueck, A. C.; Mitchell, S. A.; Mamon, H.; Weiser, M.; Saltz, L.; Gollub, M.; Rogak, L.; Ginos, B.; Mazza, G. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study
    Journal Article

    Saltz, L. B.; Clarke, S.; Díaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, T. S.; Rivera, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save